Clinical Trial Update: Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy [Phase 2]

View source ↗

Summary

Phase II evaluation of low-dose oral etoposide for relapsed or progressed AIDS-related Kaposi's sarcoma after systemic chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Kaposi Sarcoma

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED